Mechanistic Study of Ocrevus
NCT04459988
·
clinicaltrials.gov ↗
COMPLETED
Status
35
Enrollment
OTHER
Sponsor class
Conditions
Multiple Sclerosis
Interventions
DRUG:
Ocrelizumab
Sponsor
University of Michigan